Disease types associated with NAFLD present a tremendous research and development challenge for life sciences organizations and also a great opportunity for them to create value and innovation. The NASH market alone was valued at $1,179 million in 2017, and is expected to reach $21,478 million by 2025, growing at a CAGR of 58.4% from 2021 to 2025 1.

The graphic below shows some example insights in non-alcoholic fatty liver disease (NAFLD) and its common disease type NASH (non-alcoholic steatohepatitis) extracted from our Dimensions platform.

Digital Science offers the data capabilities to help information services leaders, discovery scientists, CI analysts, knowledge management, partnering and business development professionals uncover insights and expertise in disease-related topics and key indication areas.

To find out more, or to arrange a demo, please get in touch using the contact us form below.